Adults with diabetes who used a GLP-1 receptor agonist and underwent surgery requiring general anesthesia had similar odds for postsurgical complications as those receiving other oral diabetes medications, according to study data.
The findings were published in Diabetes, Obesity and Metabolism.
Artificial intelligence may allow health care providers to combine large data sources to identify and calculate likely outcomes for individual patients, which may prove helpful in diabetes care, according to experts. “The idea is that the information is so detailed and you have access to so many patients in your large database that you can make a good prediction of what’s going to
Regulatory News: BIOCORP (FR0012788065 ALCOR Eligible PEA-PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, announces the